These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35822309)

  • 1. Changes in prognosis of the Danish multiple sclerosis population over time.
    Magyari M; Joensen H; Kopp TI; Pontieri L; Koch-Henriksen N
    Mult Scler; 2022 Dec; 28(14):2190-2201. PubMed ID: 35822309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
    Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
    JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort.
    Andersen JB; Wandall-Holm MF; Andersen PK; Sellebjerg F; Magyari M
    Mult Scler; 2022 Jul; 28(8):1239-1247. PubMed ID: 34791952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapses add to permanent disability in relapsing multiple sclerosis patients.
    Koch-Henriksen N; Sørensen PS; Magyari M
    Mult Scler Relat Disord; 2021 Aug; 53():103029. PubMed ID: 34116481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
    Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
    Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone therapy and disease activity in Danish women with multiple sclerosis: A population-based cohort study.
    Kopp TI; Lidegaard Ø; Magyari M
    Eur J Neurol; 2022 Jun; 29(6):1753-1762. PubMed ID: 35196406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis.
    Baroncini D; Simone M; Iaffaldano P; Brescia Morra V; Lanzillo R; Filippi M; Romeo M; Patti F; Chisari CG; Cocco E; Fenu G; Salemi G; Ragonese P; Inglese M; Cellerino M; Margari L; Comi G; Zaffaroni M; Ghezzi A;
    JAMA Neurol; 2021 Jun; 78(6):726-735. PubMed ID: 33938921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.
    Amato MP; Fonderico M; Portaccio E; Pastò L; Razzolini L; Prestipino E; Bellinvia A; Tudisco L; Fratangelo R; Comi G; Patti F; De Luca G; Brescia Morra V; Cocco E; Pozzilli C; Sola P; Bergamaschi R; Salemi G; Inglese M; Millefiorini E; Galgani S; Zaffaroni M; Ghezzi A; Salvetti M; Lus G; Florio C; Totaro R; Granella F; Vianello M; Gatto M; Di Battista G; Aguglia U; Logullo FO; Simone M; Lucisano G; Iaffaldano P; Trojano M
    Brain; 2020 Oct; 143(10):3013-3024. PubMed ID: 32935843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary study of multiple sclerosis disability in South East Wales.
    Harding KE; Ingram G; Tallantyre EC; Joseph F; Wardle M; Pickersgill TP; Willis MD; Tomassini V; Pearson OR; Robertson NP
    J Neurol Neurosurg Psychiatry; 2023 Apr; 94(4):272-279. PubMed ID: 36328420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of long-term disability in Chinese patients with multiple sclerosis: A prospective cohort study.
    Zhang Y; Xu Y; Xu T; Yin H; Zhu Y; Peng B; Cui L
    Mult Scler Relat Disord; 2020 Nov; 46():102461. PubMed ID: 32862039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset MS is associated with an increased rate of reaching disability milestones.
    Andersen MA; Buron MD; Magyari M
    J Neurol; 2021 Sep; 268(9):3352-3360. PubMed ID: 33677675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term disability progression of pediatric-onset multiple sclerosis.
    McKay KA; Hillert J; Manouchehrinia A
    Neurology; 2019 Jun; 92(24):e2764-e2773. PubMed ID: 31092624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
    Portaccio E; Bellinvia A; Fonderico M; Pastò L; Razzolini L; Totaro R; Spitaleri D; Lugaresi A; Cocco E; Onofrj M; Di Palma F; Patti F; Maimone D; Valentino P; Confalonieri P; Protti A; Sola P; Lus G; Maniscalco GT; Brescia Morra V; Salemi G; Granella F; Pesci I; Bergamaschi R; Aguglia U; Vianello M; Simone M; Lepore V; Iaffaldano P; Filippi M; Trojano M; Amato MP
    Brain; 2022 Aug; 145(8):2796-2805. PubMed ID: 35325059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
    Kerbrat A; Hamonic S; Leray E; Tron I; Edan G; Yaouanq J;
    Eur J Neurol; 2015 Mar; 22(3):507-e35. PubMed ID: 25515927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.
    D'Amico E; Patti F; Zanghì A; Chisari CG; Lo Fermo S; Zappia M
    Eur J Neurol; 2018 Dec; 25(12):1425-1431. PubMed ID: 29956427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal patterns of relapse and disability in Danish MS patients: A population-based cohort study.
    Elser HC; Koch-Henriksen N; Magyari M
    Mult Scler Relat Disord; 2021 Apr; 49():102739. PubMed ID: 33450501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial multiple sclerosis patients have a shorter delay in diagnosis than sporadic cases.
    Steenhof M; Stenager E; Nielsen NM; Kyvik K; Möller S; Hertz JM
    Mult Scler Relat Disord; 2019 Jul; 32():97-102. PubMed ID: 31078918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
    Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening of disability caused by relapses in multiple sclerosis: A different approach.
    Koch-Henriksen N; Thygesen LC; Sørensen PS; Magyari M
    Mult Scler Relat Disord; 2019 Jul; 32():1-8. PubMed ID: 31003200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.